- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | bonyf Group Confirms Strategic Transformation and Long-Term Growth Vision | - | Euronext | ||
| 30.06. | BONYF: bonyf NV Annual General Meeting Approves 2025 Financial Statements and Reaffirms Growth Strategy | 1 | Euronext | ||
| 20.05. | BONYF: bonyf NV - Annual General Meeting Date and Business Update | 2 | Euronext | ||
| 24.04. | BONYF: Update on General Shareholders' Meeting and Periocream Launch in Italy | - | Euronext | ||
| 31.03. | BONYF: bonyf NV - Notice of General Meeting & Business Update | 5 | Euronext | ||
| 25.02. | BONYF: bonyf provides strategic update on PerioCream commercial expansion and Nasdaq listing plans | 1 | Euronext | ||
| 27.01. | BONYF: bonyf - A Year of Certification, Innovation and Commercial Acceleration | 1 | Euronext | ||
| 15.10.25 | bonyf AG receives the EU-MDR Certification Class IIa for PerioCream | 548 | Dow Jones News | DJ bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
bonyf NV / Key word(s): Product Launch/Incoming Orders
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream... ► Artikel lesen | |
| BONYF Aktie jetzt für 0€ handeln | |||||
| 15.09.25 | bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf | 561 | Dow Jones News | DJ bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf
bonyf NV / Key word(s): Conference/Corporate Action
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm... ► Artikel lesen | |
| 05.09.25 | bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments | 439 | Dow Jones News | DJ bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
bonyf NV / Key word(s): Financing/Corporate Action
bonyf NV Cancels Planned Capital Increase Following Positive... ► Artikel lesen | |
| 11.08.25 | Periocream: The Future Commercial Winner for bonyf | 635 | Dow Jones News | DJ Periocream: The Future Commercial Winner for bonyf
bonyf NV / Key word(s): Market Launch/Development of Sales
Periocream: The Future Commercial Winner for bonyf
11-Aug-2025 / 15:16 CET/CEST... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results |
Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| FRESENIUS MEDICAL CARE | 42,760 | +1,09 % | BERNSTEIN RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung von Fresenius Medical Care (FMC) mit "Market-Perform" und einem Kursziel von 44,65 Euro gestartet. Mit der Markteinführung... ► Artikel lesen | |
| FRESENIUS | 43,260 | +1,34 % | Fresenius: Hoffnungen auf Prognoseanhebung und Kurssprung | Fresenius steht möglicherweise vor einer Anhebung seiner Jahresprognose, nachdem Analysten ein starkes zweites Quartal erwarten. Die Deutsche Bank sieht weiteres Kurspotenzial und hält trotz bereits... ► Artikel lesen | |
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,580 | -1,71 % | ANALYSE-FLASH: UBS belässt Siemens Healthineers auf 'Neutral' - Ziel 38 Euro | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 38 Euro auf "Neutral" belassen. In der Radiotherapie heiße es nicht mehr nur... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| AVEANNA HEALTHCARE | 9,690 | 0,00 % | Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10 | ||
| CARL ZEISS MEDITEC | 27,760 | -3,41 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. In einem am Dienstag vorliegenden Ausblick... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 31,750 | -0,06 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| HEARTFLOW | 24,540 | -0,08 % | Stifel reiterates HeartFlow stock rating after cardiology meeting |
BONYF NV gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONYF NV finden Sie auf Wallstreet Online.